|
--- |
|
dataset_info: |
|
features: |
|
- name: uid |
|
dtype: string |
|
- name: premise |
|
dtype: string |
|
- name: hypothesis |
|
dtype: string |
|
- name: label |
|
dtype: |
|
class_label: |
|
names: |
|
'0': entailment |
|
'1': neutral |
|
'2': contradiction |
|
- name: reason |
|
dtype: string |
|
splits: |
|
- name: train |
|
num_bytes: 44720719 |
|
num_examples: 100459 |
|
- name: validation |
|
num_bytes: 663148 |
|
num_examples: 1200 |
|
- name: test |
|
num_bytes: 657586 |
|
num_examples: 1200 |
|
download_size: 15202058 |
|
dataset_size: 46041453 |
|
--- |
|
# The Adversarial Natural Language Inference (ANLI) |
|
|
|
- Source: https://huggingface.co/datasets/anli |
|
- Num examples: |
|
- 100,459 (train) |
|
- 1,200 (validation) |
|
- 1,200 (test) |
|
- Language: English |
|
|
|
```python |
|
from datasets import load_dataset |
|
|
|
load_dataset("vietgpt/anli_r3_en") |
|
``` |
|
|
|
- Format for NLI task |
|
|
|
```python |
|
def preprocess(sample): |
|
premise = sample['premise'] |
|
hypothesis = sample['hypothesis'] |
|
label = sample['label'] |
|
|
|
if label == 0: |
|
label = "entailment" |
|
elif label == 1: |
|
label = "neutral" |
|
else: |
|
label = "contradiction" |
|
return {'text': f'<|startoftext|><|premise|> {premise} <|hypothesis|> {hypothesis} <|label|> {label} <|endoftext|>'} |
|
|
|
""" |
|
<|startoftext|><|premise|> TOKYO, Dec 18 (Reuters) - Japan’s Shionogi & Co said on Tuesday that it has applied to health regulators in the United States, Canada and Europe for approval of its HIV drug Dolutegravir. Shionogi developed Dolutegravir with a Viiv Healthcare, an AIDS drug joint venture between GlaxoSmithKline and Pfizer, in exchange for its rights to the drug. <|hypothesis|> The article was written on December 18th. <|label|> entailment <|endoftext|> |
|
""" |
|
``` |